CD99 is a therapeutic target on disease stem cells in myeloid malignancies.

CD99 is a therapeutic target on disease stem cells in myeloid malignancies.

Item
http://www.wikidata.org/entity/Q38998882
Stem and progenitor cell alterations in myelodysplastic syndromes.CD99 at the crossroads of physiology and pathology.Pilot Study on Mass Spectrometry-Based Analysis of the Proteome of CD34⁺CD123⁺ Progenitor Cells for the Identification of Potential Targets for Immunotherapy in Acute Myeloid Leukemia.Tumor suppressor CD99 is downregulated in plasma cell neoplasms lacking CCND1 translocation and distinguishes neoplastic from normal plasma cells and B-cell lymphomas with plasmacytic differentiation from primary plasma cell neoplasms.snoRNAs contribute to myeloid leukaemogenesis.CD99: A Cell Surface Protein with an Oncojanus Role in Tumors.Universal monitoring of minimal residual disease in acute myeloid leukemia.Phenotypic characterization of aberrant stem and progenitor cell populations in myelodysplastic syndromes.Characterization and targeting of malignant stem cells in patients with advanced myelodysplastic syndromes
P2860

CD99 is a therapeutic target on disease stem cells in myeloid malignancies.

Item
http://www.wikidata.org/entity/Q38998882
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
CD99 is a therapeutic target on disease stem cells in myeloid malignancies.
@en
type
label
CD99 is a therapeutic target on disease stem cells in myeloid malignancies.
@en
prefLabel
CD99 is a therapeutic target on disease stem cells in myeloid malignancies.
@en
P1433
P1476
P2093
P2860
P31
P356
P407
P433
P478
P577
P698
P932
P356
P1433
P1476
CD99 is a therapeutic target on disease stem cells in myeloid malignancies.
@en
P2093
P2860
P31
P356
10.1126/SCITRANSLMED.AAJ2025
P407
P433
P478
P577
P698
P932